Indivior Pharmaceuticals, Inc. (INDV) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $195.00M | -38.9% |
| 2024 | $319.00M | +0.9% |
| 2023 | $316.00M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $195.00M | -38.9% |
| 2024 | $319.00M | +0.9% |
| 2023 | $316.00M | — |